New Cosponsor — Mar 8, 2012
New Cosponsor: Sen. Susan Collins [R-ME]
The bill now has 5 cosponsors (3 Democrats, 2 Republicans).
Apr 14, 2011
112th Congress, 2011–2013
This bill was introduced on July 28, 2011, in a previous session of Congress, but was not enacted.
Senator from Minnesota
Read Text »
Last Updated: Jul 28, 2011
Length: 4 pages
A bill to ban the sale of certain synthetic drugs.
7/28/2011--Reported to Senate without amendment.Combating Designer Drugs Act of 2011 - Amends the Controlled Substances Act to include as a Schedule I controlled substance any material, compound, mixture, or preparation ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
Reported by Committee
A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 839”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 839 — 112th Congress: Combating Designer Drugs Act of 2011. Retrieved from https://www.govtrack.us/congress/bills/112/s839
“S. 839 — 112th Congress: Combating Designer Drugs Act of 2011.” www.GovTrack.us. 2011. October 6, 2015 <https://www.govtrack.us/congress/bills/112/s839>
|title=S. 839 (112th)
|accessdate=October 6, 2015
|author=112th Congress (2011)
|date=April 14, 2011
|quote=Combating Designer Drugs Act of 2011